Works matching IS 87551225 AND DT 2019 AND VI 35 AND IP 3
Results: 6
Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban.
- Published in:
- Journal of Pharmacy Technology, 2019, v. 35, n. 3, p. 119, doi. 10.1177/8755122519839437
- By:
- Publication type:
- Article
Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes.
- Published in:
- Journal of Pharmacy Technology, 2019, v. 35, n. 3, p. 105, doi. 10.1177/8755122519838848
- By:
- Publication type:
- Article
Factors Associated With an Interest in Practice-Based Research Among Pharmacists in Nigeria.
- Published in:
- Journal of Pharmacy Technology, 2019, v. 35, n. 3, p. 98, doi. 10.1177/8755122519831384
- By:
- Publication type:
- Article
Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
- Published in:
- Journal of Pharmacy Technology, 2019, v. 35, n. 3, p. 110, doi. 10.1177/8755122519834615
- By:
- Publication type:
- Article
Investigation Into the Pharmacist's Role in Breastfeeding Support in the "Roma B" Local Health Authority in Rome.
- Published in:
- Journal of Pharmacy Technology, 2019, v. 35, n. 3, p. 91, doi. 10.1177/8755122518823022
- By:
- Publication type:
- Article
Evidence-Based Review of Smartphone Versus Paper Asthma Action Plans on Asthma Control.
- Published in:
- Journal of Pharmacy Technology, 2019, v. 35, n. 3, p. 126, doi. 10.1177/8755122519830446
- By:
- Publication type:
- Article